Fig. 3From: Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experienceKaplan-Meier estimates of progression-free survival (PFS). a PFS for patients of different ages. b PFS for patients who received different extents of surgical resection. c PFS for patients with different numbers of adjuvant TMZ cyclesBack to article page